Document Detail


Etoposide induces a mixed type of programmed cell death and overcomes the resistance conferred by Bcl-2 in Hep3B hepatoma cells.
MedLine Citation:
PMID:  22895528     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
The Bcl-2 protein is known to exert not only anti-apoptotic but also anti-autophagic activities. Numerous studies have demonstrated that etoposide, which is one of the most widely used cancer chemotherapy agents, induces apoptotic cell death. However, the exact molecular mechanism leading to cell death by etoposide remains to be resolved. This study aimed to dissect the mode of cell death induced by etoposide in Hep3B hepatoma cells. Furthermore, this study was conducted to examine whether etoposide overcomes the resistance conferred by Bcl-2 in Hep3B hepatoma cells. We observed that Hep3B cells treated with etoposide show not only apoptotic but autophagic phenotypes. Autophagy inhibition by 3-methyladenine (3MA) and caspase inhibition by zVAD-fmk effectively decreased autophagic and apoptotic phenotypes, respectively. However, either zVAD-fmk or 3MA only partially prevented cell death. These data indicate that etoposide concomitantly induces autophagic cell death and apoptosis in Hep3B cells. Importantly, etoposide can effectively induce cell death in Bcl-2-overexpressing Hep3B cells. Conversely, staurosporine, which exclusively induces apoptosis in Hep3B cells, did not efficiently induce cell death in Bcl‑2‑overexpressing Hep3B cells. Staurosporine-treated Hep3B cells also showed an autophagic phenotype. While autophagy is cell death-inducing in Hep3B cells treated with etoposide, it is cytoprotective in Hep3B cells treated with staurosporine. To this end, we observed that etoposide-induced mixed type of programmed cell death is associated with the dissociation of Bcl-2 from Beclin-1. Taken together, etoposide induces a mixed type of programmed cell death and overcomes the resistance conferred by Bcl-2 in Hep3B hepatoma cells.
Authors:
Seung Hee Yoo; Young Geol Yoon; Jee Suk Lee; Yeon Suk Song; Joon Seok Oh; Bong Soo Park; Taeg Kyu Kwon; Cheol Park; Yung Hyun Choi; Young Hyun Yoo
Related Documents :
7279058 - Contact of migrating l5222 leukemia cells with the substrate as studied under the actio...
18206378 - Grafts of extra-adrenal chromaffin cells as aggregates show better survival rate and re...
22584948 - Acquired resistance to peloruside a and laulimalide is associated with downregulation o...
14658498 - Mutation of the dictyostelium fbxa gene affects cell-fate decisions and spatial pattern...
15842628 - Marking cell lineages in living tissues.
21818608 - The abc1 ( - )/coq8 ( - ) respiratory-deficient mutant of schizosaccharomyces pombe suf...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-8-07
Journal Detail:
Title:  International journal of oncology     Volume:  -     ISSN:  1791-2423     ISO Abbreviation:  Int. J. Oncol.     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-8-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9306042     Medline TA:  Int J Oncol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Anatomy and Cell Biology and Mitochondria Hub Regulation Center, College of Medicine, Dong-A University, Busan, Republic of Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Evaluation of the interactions of HIV-1 integrase with small ubiquitin-like modifiers and their conj...
Next Document:  Solute transport on the sub 100 ms scale across the lipid bilayer membrane of individual proteolipos...